CIK 0001719406 · Non-accelerated filer<br>Smaller reporting company
NRX Pharmaceuticals, Inc.
Sign in to watch- Ticker
- NRXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822844431
- Phone
- 484-254-6134
- Business address
- 1201 ORANGE STREET, SUITE 600, WILMINGTON, DE, 19801
- Former names
- Big Rock Partners Acquisition Corp.
- 8-K Event Other events
- 8-K Event Material agreement · Unregistered share sale · Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Material agreement
- 8-K Event Material agreement · Other events
- 8-K Event Delisting notice
- 8-K Event Delisting notice · Regulation FD disclosure
- 3 Insider Initial Statement of Ownership
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Executive or director change · Shareholder vote results
- 8-K Event Other events
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 8-K/A Event Auditor change
- 8-K Event Auditor change
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Delisting notice
- 3 Insider Initial Statement of Ownership
Page 7 of 24 · 479 filings